TCM
EVH icon

Teza Capital Management’s Evolent Health EVH Stock Holding History

Teza Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,317
Closed -$222K – 640
2023
Q2 		$222K Buy
+7,317
New +$237K 0.04% 486

Other funds holding EVH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Teza Capital Management's EVH Position: Q3 2023 in Review

Teza Capital Management sold out of Evolent Health (EVH) in Q3 2023, closing a stake of 7,317 shares — an estimated $222K sold.

Teza Capital Management first reported a position in EVH in Q2 2023 and held it in 1 quarter. The position peaked at $222K in Q2 2023. 203 funds tracked by Wall St. Rank hold EVH as of Q3 2023.

  • Teza Capital Management reported no remaining Evolent Health position as of Q3 2023 after selling out during the quarter.
  • Teza Capital Management sold 7,317 Evolent Health shares in Q3 2023, an estimated $222K.
  • Teza Capital Management first reported a position in Evolent Health in Q2 2023 and held it in 1 quarter.
  • Teza Capital Management's Evolent Health position peaked at $222K in Q2 2023.
  • 203 funds tracked by Wall St. Rank held Evolent Health as of Q3 2023.

Based on Teza Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.